Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II-infused apoE-deficient mice

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 3, 2009, Pages 164-171

  Inoue, Nao ^a   Muramatsu, Michiko ^a   Jin, Denan ^a   Takai, Shinji ^a   Hayashi, Tetsuya ^a   Katayama, Hiroshi ^a   Kitaura, Yasushi ^a   Tamai, Hiroshi ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Aneurysm; Angiotensin II; Angiotensin converting enzyme; Chymase

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; CANDESARTAN; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; GELATINASE B; LISINOPRIL;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MOUSE; HISTOPATHOLOGY; MOUSE; NONHUMAN; RECEPTOR BLOCKING; SYSTOLIC BLOOD PRESSURE;

EID: 70350215665     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E611     Document Type: Article

References (35)

1. Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW: Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol, 1997; 150:993-1007
2. Powell JT, Brady AR: Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 2004; 24:241-245
3. Thompson RW: Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. Curr Opin Cardiol, 1996; 11:504-518
4. Ballotta E, Toniato A: Small abdominal aortic aneurysms. N Engl J Med, 2002; 347:1112-1115
5. Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest, 2000; 105:1605-1612
6. Daugherty A, Cassis LA: Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 2004; 24:429-434
7. Zhou Y, Chen R, Catanzaro SE, Hu L, Dansky HM, Catanzaro DF: Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice. Am J Hypertens, 2005; 18:486-492
8. Takai S, Shiota N, Sakaguchi M, Muraguchi H, Matsumura E, Miyazaki M: Characterization of chymase from human vascular tissues. Clin Chim Acta, 1997; 265:13-20
9. Takai S, Jin D, Sakaguchi M, Miyazaki M: Chymase-dependent angiotensin II formation in human vascular tissue. Circulation, 1999; 100:654-658
10. Rouet-Benzineb P, Gontero B, Dreyfus P, Lafuma C: Angiotensin II induces nuclear factor-kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J Mol Cell Cardiol, 2000; 32:1767-1778
11. Ihara M, Urata H, Kinoshita A, Suzumiya J, Sasaguri M, Kikuchi M, Ideishi M, Arakawa K: Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension, 1999; 33:1399-1405
12. Nishimoto M, Takai S, Fukumoto H, Tsunemi K, Yuda A, Sawada Y, Yamada M, Jin D, Sakaguchi M, Nishimoto Y, Sasaki S, Miyazaki M: Increased local angiotensin II formation in aneurysmal aorta. Life Sci, 2002; 71:2195-2205
13. Tsunemi K, Takai S, Nishimoto M, Yuda A, Hasegawa S, Sawada Y, Fukumoto H, Sasaki S, Miyazaki M: Possible roles of angiotensin II-forming enzymes, angiotensin converting enzyme and chymase-like enzyme, in the human aneurysmal aorta. Hypertens Res, 2002; 25:817-822
14. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC: Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest, 1995; 96:318-326
15. Ejiri J, Inoue N, Tsukube T, Munezane T, Hino Y, Kobayashi S, Hirata K, Kawashima S, Imajoh-Ohmi S, Hayashi Y, Yokozaki H, Okita Y, Yokoyama M: Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc Res, 2003; 59:988-996
16. Lu H, Rateri DL, Cassis LA, Daugherty A: The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep, 2008; 10:99-106
17. Wang YX, Martin-McNulty B, Freay AD, Sukovich DA, Halks-Miller M, Li WW, Vergona R, Sullivan ME, Morser J, Dole WP, Deng GG: Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol, 2001; 159:1455-1464
18. Kirimura K, Takai S, Jin D, Muramatsu M, Kishi K, Yoshikawa K, Nakabayashi M, Mino Y, Miyazaki M: Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats. Hypertens Res, 2005; 28:457-464
19. Furubayashi K, Takai S, Jin D, Muramatsu M, Ibaraki T, Nishimoto M, Fukumoto H, Katsumata T, Miyazaki M: The significance of chymase in the progression of abdominal aortic aneurysms in dogs. Hypertens Res, 2007; 30:349-357
20. Manning MW, Cassis LA, Huang J, Szilvassy SJ, Daugherty A: Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med, 2002; 7:45-54
21. Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, Ichikawa I, Fazio S, Kon V: Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis, 2006; 184:312-321
22. Chen J, Kuhlencordt PJ, Astern J, Gyurko R, Huang PL: Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation, 2001; 104:2391-2394
23. Okamura A, Rakugi H, Ohishi M, Yanagitani Y, Takiuchi S, Moriguchi K, Fennessy PA, Higaki J, Ogihara T: Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertens, 1999; 17:537-545
24. Okamoto Y, Takai S, Yamada M, Miyazaki M: Chymase inhibitors may prevent postoperative adhesion formation. Fertil Steril, 2002; 77:1044-1048
25. Maruichi M, Takai S, Sugiyama T, Ueki M, Oku H, Sakaguchi M, Okamoto Y, Muramatsu M, Ikeda T, Miyazaki M: Role of chymase on growth of cultured canine Tenon's capsule fibroblasts and scarring in a canine conjunctival flap model. Exp Eye Res, 2004; 79:111-118
26. Takai S, Jin D, Sakaguchi M, Katayama S, Muramatsu M, Sakaguchi M, Matsumura E, Kim S, Miyazaki M: A novel chymase inhibitor, 4-(1-((bis-(4-methyl-phenyl)-methyl)-carbamoyl)3-(2-ethoxy-benzyl)- 4-oxo-azetidine-2-yloxy)-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. J Pharmacol Exp Ther, 2003; 305:17-23
27. Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, Lu HS, Schechter NM: Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA, 1997; 94:9017-9021
28. Hernández-Presa MA, Bustos C, Ortego M, Tuñón J, Ortega L, Egido J: Angiotensin -converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation, 1997; 95:1532-1541
29. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res, 1998; 83:952-959
30. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest, 2000; 105:1641-1649
31. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT: Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest, 2002; 110:625-632
32. Manning MW, Cassis LA, Daugherty A: Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 2003; 23:483-488
33. Jin D, Takai S, Shiota N, Miyazaki M: Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters. J Hypertens, 1998; 16: 657-664
34. Sorbi D, Fadly M, Hicks R, Alexander S, Arbeit L: Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. Kidney Int, 1993; 44:1266-1272
35. Yamamoto D, Takai S, Miyazaki M: Prediction of interaction mode between a typical ACE inhibitor and MMP-9 active site. Biochem Biophys Res Commun, 2007; 354:981-984